تحميل...

Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling

BACKGROUND: Cabotegravir and rilpivirine are 2 long-acting (LA) antiretrovirals that can be administered intramuscularly; their interaction with rifampicin, a first-line antituberculosis agent, has not been investigated. The aim of this study was to simulate and predict drug–drug interactions (DDIs)...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	J Infect Dis
المؤلفون الرئيسيون:	Rajoli, Rajith K R, Curley, Paul, Chiong, Justin, Back, David, Flexner, Charles, Owen, Andrew, Siccardi, Marco
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Oxford University Press 2019
الموضوعات:	Major Articles and Brief Reports
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6500558/ https://ncbi.nlm.nih.gov/pubmed/30566691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy726
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling

مواد مشابهة